Edges in Network
| Network | GSE5851_top8000 - GSE5851 - SiGN-BN NNSR |
| Network Description | Phase II exploratory pharmacogenomics study of cetuximab monotherapy in patients with advanced metastatic CRC |
| Node | CDHR5 |
| Upstream (Parents) |
|---|
| (<<) SLC37A4 → CDHR5 |
| (<<) NR5A2 → CDHR5 |
| (<<) SLC17A4 → CDHR5 |
| (<<) ENTPD5 → CDHR5 |
| (<<) NAT2 → CDHR5 |
| Downstream (Children) |
|---|
| CDHR5 → GLT25D2 (>>) |
| CDHR5 → BIN1 (>>) |
| CDHR5 → CADM3 (>>) |
| CDHR5 → ABTB2 (>>) |
| CDHR5 → HIST1H2BD (>>) |
| CDHR5 → PPARGC1A (>>) |
| CDHR5 → RRN3P1 (>>) |
| CDHR5 → CACNG5 (>>) |
| CDHR5 → GRRP1 (>>) |
| CDHR5 → BCKDHB (>>) |
| CDHR5 → DHRS2 (>>) |
| CDHR5 → RUFY3 (>>) |
